| My Account | Subscribe | Contact Us | Donate |
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
If you are a physician, educator and medical professional who focus on the treatment of diabetes, then this is the must have resource for you.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
You can cancel your newsletter subscription at anytime by clicking "Unsubscribe" on the bottom of any newsletter you receive
Then enter your new email address in the above form and click "Subscribe"
Related Community Threads on Diabetes Health Forums
The Flamingo Flock diabetes awareness campaign is the brainchild of 9-year-old Noah Brokmeier, "The Diabetes Dude." Noah's blue flamingos are landing on lawns nationwide and appearing at big events like the Boston Marathon. Wherever they go, the birds pose for pictures, which are then posted on Noah's website, www.thediabetesdude.com. The location of the birds is also flagged on his "official flamingo tracking map," to show the progress and growth of the campaign.
1 comment - Aug 30, 2010 -
MannKind Corporation announced that the company will supply its novel, ultra rapid acting insulin AFREZZATM (insulin human [rDNA origin]) for use in a study being conducted by the Juvenile Diabetes Research Foundation (JDRF) as part of its Artificial Pancreas Project. The planned two-year study in patients with type 1 diabetes will leverage the unique rapid action of AFREZZA for use in a closed-loop blood sugar monitoring and insulin delivery system, termed the "artificial pancreas" by the JDRF. The study will be managed in conjunction with the Sansum Diabetes Research Institute and the University of California, Santa Barbara.
0 comments - Aug 29, 2010 -
Working toward the goal of unifying patients' diabetic treatment information in a single place, the PositiveID Corporation hopes to patent a new device that monitors insulin pens. The Insulin Tracker would attach to a user's insulin pen and record the times and amounts of injections. That information would then be sent to a database that allows for comprehensive monitoring. Insulin pens come in disposable and cartridge-replaceable flavors; the tracker can be moved easily from one pen to another.
0 comments - Aug 27, 2010 -
Hi Everyone! Just wanted to let everyone know about a big event I have coming up! Next Thursday, August 26th, I am chartering a bus that I am filling with 50 of my closest friends with diabetes and traveling from Taunton, MA to New York City to invade the Today Show on NBC with my blue flamingos! This is a once in a lifetime opportunity to make a HUGE impact on people and let everyone know about my campaign! I hope that by doing this, people will realize that diabetes is a REAL disease that effects so many of us, young and old, and I hope to encourage people from all over the country to get out and do something to help raise diabetes awareness just like me and my friends!
1 comment - Aug 25, 2010 -
Novo Nordisk announced today the availability of NovoDoseTM - the first-ever mobile insulin dosing guide for physicians to look up dosing guidelines and blood glucose goals for their patients with diabetes, a disease that affects nearly 24 million Americans. The guide is available as an application on iTunes and is specific to Novo Nordisk's modern insulin analog portfolio: Levemir® (insulin detemir [rDNA origin] injection), NovoLog® (insulin aspart [rDNA origin] injection), and NovoLog® Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin]).
1 comment - Aug 24, 2010 -
Gene variants associated with an increased risk for type-1 diabetes and rheumatoid arthritis may confer previously unknown benefits to their human carriers, say researchers at the Stanford University School of Medicine. As a result, the human race may have been evolving in the recent past to be more susceptible, rather than less, to some complex diseases, they conclude.
1 comment - Aug 21, 2010 -
Laser eye surgery is becoming increasingly popular as more and more people look to free themselves from their glasses or contact lenses. There are two main types of laser eye surgery, Lasik and Lasek. The vast majority of people choose to have Lasik because it has a far quicker and more comfortable recovery period. Most people can return to work and normal activities within 48 hours of having Lasik, whereas it can take up to a week to recover from Lasek surgery. In some instances your surgeon may insist that you have Lasik--if, for example, you are involved in contact sports.
2 comments - Aug 16, 2010 -
"The objective of this clinical trial (research study) is to determine if the medications can rescue the few beta cells that remain soon after the diagnosis of type 1 diabetes; and whether new beta cells can even be regenerated," commented Alex Rabinovitch, MD, Principal Investigator of the trial and Associate Director of The Sanford Project. "The investigational combinations of these medications could possibly allow patients to decrease or no longer need to inject insulin to keep their blood levels under proper control."
1 comment - Aug 12, 2010 -
We can all come up with plenty of excuses not to test our blood sugar. For one, yeah, it stings a little (No pain, no gain, the angel on my shoulder whispers in my ear). For another, testing isn't convenient, no matter how quickly the meter works or how small it is. While seemingly everyone else is carelessly enjoying a meal or leaping into the swimming pool, you are on the sidelines trying to ignore your diabetes. And of course, sometimes, we just do not want to know what the number will be. It's easier to ignore the ugly truth than face it.
5 comments - Aug 3, 2010 -